Category: Neuroblastoma Research

Improved screening means new targets for pediatric neuroblastoma therapies

Neuroblastoma is one of the most common and lethal types of childhood cancers. In a paper published online today in OncoTarget, a researcher at the University of Texas Health Science Center at San Antonio unveils the important role of microRNAs in regulating neuroblastoma development, pointing to new therapeutic possibilities. http://www.sciencecodex.com/improved_screening_means_new_targets_for_pediatric_neuroblastoma_therapies-128860

read more

New hope in the fight against neuroblastoma!

I knew those extra computer cycles would pay off someday! If you’re not participating in some way, you should. They have a bunch of worthy research. Our research team at the Chiba Cancer Center in Japan has been working to develop a new treatment for neuroblastoma. With the help of volunteers participating in the IBM World Community Grid initiative, we […]

read more

Researchers develop smartglasses that help surgeons see cancerous cells

Something like this would be very good to have for Neuroblastoma. One of the concerns I had with Ben’s first relapse was making sure that the surgeon got out all of the cancer. We even had Dr. Laqualia, at Sloan Kettering, open Ben again to make sure it was all gone. This would make a skilled surgeon a master, for […]

read more

Cancer Diagnosis Doesn’t Increase a Child’s Risk of Post-Traumatic Stress Disorder

Very interesting… I don’t think Ben has PTSD, mainly because most of his treatment has been while he’s young. That being said, it’s something I’ll certainly be on the lookout for. A St. Jude Children’s Research Hospital study found that despite being diagnosed with life-threatening illnesses, childhood cancer patients are no more likely than their healthy peers to develop post-traumatic […]

read more

New Findings from Texas Tech University School of Medicine in the Area of Immunotherapy Described

Data detailed on Biotechnology have been presented. According to news reporting from Lubbock, Texas, by NewsRx journalists, research stated, “Neuroblastoma (NB) is the most common extracranial solid tumor in children. Combining passive immunotherapy with an antibody to the disialoganglioside GD2 (ch14.18/SP2/0) and cytokines with 13-cis-retinoic acid for post-myeloablative maintenance therapy increased survival in high-risk NB, but the overall prognosis for these children […]

read more